UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 622

Sortiert nach

Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies

Acta neuropathologica, 2009-02, Vol.117 (2), p.137-149

2009

Volltextzugriff (PDF)

Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man

Scientific reports, 2016-06, Vol.6 (1), p.27147, Article 27147

2016

Volltextzugriff (PDF)

Frontotemporal dementia: Clinicopathological correlations

Annals of neurology, 2006-06, Vol.59 (6), p.952-962

2006

Volltextzugriff (PDF)

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

Science (American Association for the Advancement of Science), 2003-04, Vol.300 (5619), p.636-640

2003

Volltextzugriff (PDF)

VCP Mutations Causing Frontotemporal Lobar Degeneration Disrupt Localization of TDP-43 and Induce Cell Death

The Journal of biological chemistry, 2009-05, Vol.284 (18), p.12384-12398

2009

Volltextzugriff (PDF)

The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts

Neurobiology of disease, 2007-03, Vol.25 (3), p.561-570

2007

Volltextzugriff (PDF)

Transgenic Mouse Model of Tau Pathology in Astrocytes Leading to Nervous System Degeneration

The Journal of neuroscience, 2005-04, Vol.25 (14), p.3539-3550

2005

Volltextzugriff (PDF)

‘Unfolding’ pathways in neurodegenerative disease

Trends in neurosciences (Regular ed.), 2003-08, Vol.26 (8), p.407-410

2003

Volltextzugriff (PDF)

Genotypically Defined Lissencephalies Show Distinct Pathologies

Journal of neuropathology and experimental neurology, 2005-10, Vol.64 (10), p.847-857

2005

Volltextzugriff (PDF)

Impaired Glutamate Transport in a Mouse Model of Tau Pathology in Astrocytes

The Journal of neuroscience, 2006-01, Vol.26 (2), p.644-654

2006

Volltextzugriff (PDF)

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients

Science translational medicine, 2016-11, Vol.8 (363), p.363ra150

2016

Volltextzugriff (PDF)

Signature Tau Neuropathology in Gray and White Matter of Corticobasal Degeneration

The American journal of pathology, 2002-06, Vol.160 (6), p.2045-2053

2002

Volltextzugriff (PDF)

Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs

Nature medicine, 2004-10, Vol.10 (10), p.1055-1063

2004

Volltextzugriff (PDF)

TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97

The Journal of neuroscience, 2010-06, Vol.30 (22), p.7729-7739

2010

Volltextzugriff (PDF)

Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations

Annals of neurology, 2007-05, Vol.61 (5), p.427-434

2007

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK‐8931) in Healthy Japanese Adults: A Randomized, Placebo‐Controlled Study

Clinical pharmacology and therapeutics, 2019-05, Vol.105 (5), p.1234-1243

2019

Volltextzugriff (PDF)

Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies

Journal of neuropathology and experimental neurology, 2008-06, Vol.67 (6), p.555-564

2008

Volltextzugriff (PDF)

Role for Akt3/Protein Kinase Bγ in Attainment of Normal Brain Size

Molecular and Cellular Biology, 2005-03, Vol.25 (5), p.1869-1878

2005

Volltextzugriff (PDF)

TDP-43 in Familial and Sporadic Frontotemporal Lobar Degeneration with Ubiquitin Inclusions

The American journal of pathology, 2007-07, Vol.171 (1), p.227-240

2007

Volltextzugriff (PDF)

TDP-43: a novel neurodegenerative proteinopathy

Current opinion in neurobiology, 2007-10, Vol.17 (5), p.548-555

2007

Volltextzugriff (PDF)

TDP-43 in the Ubiquitin Pathology of Frontotemporal Dementia With VCP Gene Mutations

Journal of neuropathology and experimental neurology, 2007-02, Vol.66 (2), p.152-157

2007

Volltextzugriff (PDF)

Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia

American journal of medical genetics. Part A, 2008-03, Vol.146A (6), p.745-757

2008

Volltextzugriff (PDF)

Novel Ubiquitin Neuropathology in Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations

Journal of neuropathology and experimental neurology, 2006-06, Vol.65 (6), p.571-581

2006

Volltextzugriff (PDF)

Retarded Axonal Transport of R406W Mutant Tau in Transgenic Mice with a Neurodegenerative Tauopathy

The Journal of neuroscience, 2004-05, Vol.24 (19), p.4657-4667

2004

Volltextzugriff (PDF)

Axonal Degeneration Induced by Targeted Expression of Mutant Human Tau in Oligodendrocytes of Transgenic Mice That Model Glial Tauopathies

The Journal of neuroscience, 2005-10, Vol.25 (41), p.9434-9443

2005

Volltextzugriff (PDF)

1 – 25 von 622

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(554)
Mit Volltextzugriff
(551)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(617)
Japanisch
(69)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies

Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man

Frontotemporal dementia: Clinicopathological correlations

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

VCP Mutations Causing Frontotemporal Lobar Degeneration Disrupt Localization of TDP-43 and Induce Cell Death

The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts

Transgenic Mouse Model of Tau Pathology in Astrocytes Leading to Nervous System Degeneration

‘Unfolding’ pathways in neurodegenerative disease

Genotypically Defined Lissencephalies Show Distinct Pathologies

Impaired Glutamate Transport in a Mouse Model of Tau Pathology in Astrocytes

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients

Signature Tau Neuropathology in Gray and White Matter of Corticobasal Degeneration

Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs

TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97

Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations

Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK‐8931) in Healthy Japanese Adults: A Randomized, Placebo‐Controlled Study

Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies

Role for Akt3/Protein Kinase Bγ in Attainment of Normal Brain Size

TDP-43 in Familial and Sporadic Frontotemporal Lobar Degeneration with Ubiquitin Inclusions

TDP-43: a novel neurodegenerative proteinopathy

TDP-43 in the Ubiquitin Pathology of Frontotemporal Dementia With VCP Gene Mutations

Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia

Novel Ubiquitin Neuropathology in Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations

Retarded Axonal Transport of R406W Mutant Tau in Transgenic Mice with a Neurodegenerative Tauopathy

Axonal Degeneration Induced by Targeted Expression of Mutant Human Tau in Oligodendrocytes of Transgenic Mice That Model Glial Tauopathies

Suchergebnisse filtern